ONCO3.SA
Oncoclínicas do Brasil Serviços Médicos S.A. [ONCO3.SA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ONCO3.SA Stock Summary
Top 10 Correlated ETFs
ONCO3.SA
Top 10 Correlated Stocks
ONCO3.SA
In the News
ONCO3.SA Financial details
Company Rating
-
Market Cap
4.01B
Income
223.62M
Revenue
5.49B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
29.62
Forward P/E
-
PEG
0.85
P/S
1.21
P/B
2.93
P/C
-
P/FCF
-193.05
Quick Ratio
1.36
Current Ratio
1.48
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.43
EPS next Y
-
EPS next Q
-
EPS this Y
346.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
26.57%
Revenue Q/Q
2.33%
EPS Q/Q
-25%
-
-
-
-
SMA20
-34.33%
SMA50
-34.81%
SMA100
-20.36%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
10%
ROC
0.26%
Gross Margin
36%
Oper. Margin
33%
Profit Margin
4%
Payout
22%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.5-13.0
52W High
-88%
52W Low
-77.71%
RSI
35.38
Rel Volume
10.13
Avg Volume
3.08M
Volume
31.15M
Perf Week
-25.36%
Perf Month
-33.62%
Perf Quarter
-43.07%
Perf Half Y
-44.09%
-
-
-
-
Beta
1.169
-
-
Volatility
0.25%, 0.44%
Prev Close
28.93%
Price
1.56
Change
11.43%
Company Profile
- Volume Average 3.08M
- Market Capitalization 4.01B
- CEO Mr. Bruno Lemos Ferrari
- Headquarters São Paulo,SP,BR
- IPO Date 2021-09-21
-
Website
https://www.grupooncoclinicas.com 
Oncoclínicas do Brasil Serviços Médicos S.A. provides medical services focused on clinical oncology and radiotherapy in Latin America. It offers services in the areas of chemotherapy, radiotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter heparinization, non-oncological infusions, laser therapy, myelogram - bone marrow biopsy, continuous care, and precision medicine. The company was founded in 2010 and is based in São Paulo, Brazil.
